Khaled Bahi is the former CFO of Symetis, which was acquired by Boston Scientific in 2017 for $435M. He has over 20 years of medtech experience in a variety of finance leadership positions, including as the former CFO of Stilla Technologies in France and as a former finance leader for Fresenius Medical Care in France, Europe, Middle East, and Africa. Khaled earned an MSc from ETH Zürich.
Sarah Moore has over 20 years of healthcare marketing, sales, and business development experience, including strategy, product planning, and M&A. Before joining ONWARD, Sarah was Head of Commercial Marketing at Nevro, an implantable neuromodulation company. Prior to that, she held various leadership roles in global marketing across multiple Johnson & Johnson medical device franchises, most recently as the business unit leader for J&J’s Advanced Imaging business. Sarah earned an MBA from Duke University and a BA in German from Washington and Lee University.